Intervention

NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions12

Lead sponsors shown1

Clinical trials

3 shown

Trial of NanoPac Intratumoral Injection in Lung CancerNCT04314895 · 2021-04-14

Trial of NanoPac Focal Therapy for Prostate CancerNCT04221828 · 2020-10-20

Expanded Access to NanoPacNCT03756311

NO_LONGER_AVAILABLE

Common conditions

Lung Cancer2 Prostate Cancer2 Genital Neoplasms, Male1 Localized Cancer1 Locally Advanced Pancreatic Carcinoma1 Lung Cancer, Nonsmall Cell1 Lung Cancer, Small Cell1 Neoplasm of Lung1 Prostate Adenocarcinoma1 Prostate Cancer Adenocarcinoma1 Prostatic Neoplasm1 Urogenital Neoplasms1

Leading sponsors

Trial status mix

COMPLETED1

NO_LONGER_AVAILABLE1

TERMINATED1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.